nodes	percent_of_prediction	percent_of_DWPC	metapath
Terazosin—hypertension—obesity	0.549	1	CtDrD
Terazosin—ADRA1B—Phendimetrazine—obesity	0.0937	0.323	CbGbCtD
Terazosin—ADRA1A—Phendimetrazine—obesity	0.0739	0.255	CbGbCtD
Terazosin—ADRA1A—Benzphetamine—obesity	0.056	0.193	CbGbCtD
Terazosin—ADRA1A—Phenylpropanolamine—obesity	0.0535	0.184	CbGbCtD
Terazosin—ABCB1—Cimetidine—obesity	0.0129	0.0444	CbGbCtD
Terazosin—Prazosin—SLC22A1—obesity	0.000497	1	CrCbGaD
Terazosin—Rash—Diethylpropion—obesity	0.000162	0.00164	CcSEcCtD
Terazosin—Dysgeusia—Orlistat—obesity	0.000162	0.00164	CcSEcCtD
Terazosin—Dermatitis—Diethylpropion—obesity	0.000162	0.00164	CcSEcCtD
Terazosin—Dizziness—Cimetidine—obesity	0.000162	0.00163	CcSEcCtD
Terazosin—Headache—Diethylpropion—obesity	0.000161	0.00163	CcSEcCtD
Terazosin—Rhinitis—Bupropion—obesity	0.000161	0.00162	CcSEcCtD
Terazosin—Malnutrition—Sibutramine—obesity	0.00016	0.00162	CcSEcCtD
Terazosin—Back pain—Orlistat—obesity	0.00016	0.00162	CcSEcCtD
Terazosin—Libido decreased—Topiramate—obesity	0.000159	0.00161	CcSEcCtD
Terazosin—Pharyngitis—Bupropion—obesity	0.000159	0.00161	CcSEcCtD
Terazosin—Oedema peripheral—Bupropion—obesity	0.000158	0.0016	CcSEcCtD
Terazosin—Flatulence—Sibutramine—obesity	0.000158	0.00159	CcSEcCtD
Terazosin—Tension—Sibutramine—obesity	0.000157	0.00159	CcSEcCtD
Terazosin—Dysgeusia—Sibutramine—obesity	0.000157	0.00158	CcSEcCtD
Terazosin—Vision blurred—Orlistat—obesity	0.000156	0.00158	CcSEcCtD
Terazosin—Nervousness—Sibutramine—obesity	0.000156	0.00157	CcSEcCtD
Terazosin—Vomiting—Cimetidine—obesity	0.000156	0.00157	CcSEcCtD
Terazosin—Back pain—Sibutramine—obesity	0.000155	0.00156	CcSEcCtD
Terazosin—Visual impairment—Bupropion—obesity	0.000155	0.00156	CcSEcCtD
Terazosin—Rash—Cimetidine—obesity	0.000154	0.00156	CcSEcCtD
Terazosin—Dermatitis—Cimetidine—obesity	0.000154	0.00156	CcSEcCtD
Terazosin—Ill-defined disorder—Orlistat—obesity	0.000154	0.00155	CcSEcCtD
Terazosin—Headache—Cimetidine—obesity	0.000153	0.00155	CcSEcCtD
Terazosin—Nausea—Diethylpropion—obesity	0.000153	0.00154	CcSEcCtD
Terazosin—Angioedema—Orlistat—obesity	0.000151	0.00153	CcSEcCtD
Terazosin—Vision blurred—Sibutramine—obesity	0.000151	0.00152	CcSEcCtD
Terazosin—Tremor—Sibutramine—obesity	0.00015	0.00152	CcSEcCtD
Terazosin—Eye disorder—Bupropion—obesity	0.00015	0.00151	CcSEcCtD
Terazosin—Tinnitus—Bupropion—obesity	0.00015	0.00151	CcSEcCtD
Terazosin—Malaise—Orlistat—obesity	0.000149	0.00151	CcSEcCtD
Terazosin—Vertigo—Orlistat—obesity	0.000149	0.0015	CcSEcCtD
Terazosin—Ill-defined disorder—Sibutramine—obesity	0.000149	0.0015	CcSEcCtD
Terazosin—Osteoarthritis—Topiramate—obesity	0.000148	0.00149	CcSEcCtD
Terazosin—Pain in extremity—Topiramate—obesity	0.000148	0.00149	CcSEcCtD
Terazosin—Disturbance in sexual arousal—Topiramate—obesity	0.000147	0.00148	CcSEcCtD
Terazosin—Angioedema—Sibutramine—obesity	0.000146	0.00148	CcSEcCtD
Terazosin—Palpitations—Orlistat—obesity	0.000146	0.00148	CcSEcCtD
Terazosin—Migraine—Topiramate—obesity	0.000145	0.00147	CcSEcCtD
Terazosin—Nausea—Cimetidine—obesity	0.000145	0.00147	CcSEcCtD
Terazosin—Malaise—Sibutramine—obesity	0.000145	0.00146	CcSEcCtD
Terazosin—Cough—Orlistat—obesity	0.000144	0.00146	CcSEcCtD
Terazosin—Vertigo—Sibutramine—obesity	0.000144	0.00145	CcSEcCtD
Terazosin—Syncope—Sibutramine—obesity	0.000144	0.00145	CcSEcCtD
Terazosin—Convulsion—Orlistat—obesity	0.000143	0.00145	CcSEcCtD
Terazosin—Arrhythmia—Bupropion—obesity	0.000143	0.00145	CcSEcCtD
Terazosin—Face oedema—Topiramate—obesity	0.000143	0.00144	CcSEcCtD
Terazosin—Palpitations—Sibutramine—obesity	0.000142	0.00143	CcSEcCtD
Terazosin—Chest pain—Orlistat—obesity	0.000141	0.00142	CcSEcCtD
Terazosin—Myalgia—Orlistat—obesity	0.000141	0.00142	CcSEcCtD
Terazosin—Loss of consciousness—Sibutramine—obesity	0.000141	0.00142	CcSEcCtD
Terazosin—Anxiety—Orlistat—obesity	0.00014	0.00142	CcSEcCtD
Terazosin—Cough—Sibutramine—obesity	0.00014	0.00141	CcSEcCtD
Terazosin—Malnutrition—Bupropion—obesity	0.00014	0.00141	CcSEcCtD
Terazosin—Discomfort—Orlistat—obesity	0.000139	0.00141	CcSEcCtD
Terazosin—Convulsion—Sibutramine—obesity	0.000139	0.0014	CcSEcCtD
Terazosin—Dry mouth—Orlistat—obesity	0.000138	0.00139	CcSEcCtD
Terazosin—Flatulence—Bupropion—obesity	0.000138	0.00139	CcSEcCtD
Terazosin—Tension—Bupropion—obesity	0.000137	0.00138	CcSEcCtD
Terazosin—Dysgeusia—Bupropion—obesity	0.000137	0.00138	CcSEcCtD
Terazosin—Arthralgia—Sibutramine—obesity	0.000136	0.00138	CcSEcCtD
Terazosin—Chest pain—Sibutramine—obesity	0.000136	0.00138	CcSEcCtD
Terazosin—Myalgia—Sibutramine—obesity	0.000136	0.00138	CcSEcCtD
Terazosin—Anxiety—Sibutramine—obesity	0.000136	0.00137	CcSEcCtD
Terazosin—Nervousness—Bupropion—obesity	0.000136	0.00137	CcSEcCtD
Terazosin—Oedema—Orlistat—obesity	0.000135	0.00136	CcSEcCtD
Terazosin—Anaphylactic shock—Orlistat—obesity	0.000135	0.00136	CcSEcCtD
Terazosin—Back pain—Bupropion—obesity	0.000135	0.00136	CcSEcCtD
Terazosin—Orthostatic hypotension—Topiramate—obesity	0.000135	0.00136	CcSEcCtD
Terazosin—Discomfort—Sibutramine—obesity	0.000135	0.00136	CcSEcCtD
Terazosin—Hypokalaemia—Topiramate—obesity	0.000135	0.00136	CcSEcCtD
Terazosin—Dry mouth—Sibutramine—obesity	0.000133	0.00135	CcSEcCtD
Terazosin—Nasopharyngitis—Topiramate—obesity	0.000132	0.00133	CcSEcCtD
Terazosin—Confusional state—Sibutramine—obesity	0.000132	0.00133	CcSEcCtD
Terazosin—Vision blurred—Bupropion—obesity	0.000132	0.00133	CcSEcCtD
Terazosin—Tremor—Bupropion—obesity	0.000131	0.00132	CcSEcCtD
Terazosin—Gastritis—Topiramate—obesity	0.000131	0.00132	CcSEcCtD
Terazosin—Anaphylactic shock—Sibutramine—obesity	0.000131	0.00132	CcSEcCtD
Terazosin—Oedema—Sibutramine—obesity	0.000131	0.00132	CcSEcCtD
Terazosin—Hyperhidrosis—Orlistat—obesity	0.000131	0.00132	CcSEcCtD
Terazosin—Ill-defined disorder—Bupropion—obesity	0.00013	0.00131	CcSEcCtD
Terazosin—Shock—Sibutramine—obesity	0.000129	0.0013	CcSEcCtD
Terazosin—Thrombocytopenia—Sibutramine—obesity	0.000128	0.00129	CcSEcCtD
Terazosin—Asthma—Topiramate—obesity	0.000128	0.00129	CcSEcCtD
Terazosin—Angioedema—Bupropion—obesity	0.000128	0.00129	CcSEcCtD
Terazosin—Tachycardia—Sibutramine—obesity	0.000128	0.00129	CcSEcCtD
Terazosin—Hyperhidrosis—Sibutramine—obesity	0.000126	0.00128	CcSEcCtD
Terazosin—Malaise—Bupropion—obesity	0.000126	0.00127	CcSEcCtD
Terazosin—Vertigo—Bupropion—obesity	0.000126	0.00127	CcSEcCtD
Terazosin—Syncope—Bupropion—obesity	0.000125	0.00126	CcSEcCtD
Terazosin—Anorexia—Sibutramine—obesity	0.000125	0.00126	CcSEcCtD
Terazosin—Angina pectoris—Topiramate—obesity	0.000124	0.00126	CcSEcCtD
Terazosin—Palpitations—Bupropion—obesity	0.000123	0.00125	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Orlistat—obesity	0.000123	0.00124	CcSEcCtD
Terazosin—Bronchitis—Topiramate—obesity	0.000123	0.00124	CcSEcCtD
Terazosin—Loss of consciousness—Bupropion—obesity	0.000123	0.00124	CcSEcCtD
Terazosin—Insomnia—Orlistat—obesity	0.000122	0.00123	CcSEcCtD
Terazosin—Hypotension—Sibutramine—obesity	0.000122	0.00123	CcSEcCtD
Terazosin—Cough—Bupropion—obesity	0.000122	0.00123	CcSEcCtD
Terazosin—Paraesthesia—Orlistat—obesity	0.000121	0.00123	CcSEcCtD
Terazosin—Convulsion—Bupropion—obesity	0.000121	0.00122	CcSEcCtD
Terazosin—Dysuria—Topiramate—obesity	0.000119	0.00121	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Sibutramine—obesity	0.000119	0.0012	CcSEcCtD
Terazosin—Dyspepsia—Orlistat—obesity	0.000119	0.0012	CcSEcCtD
Terazosin—Myalgia—Bupropion—obesity	0.000119	0.0012	CcSEcCtD
Terazosin—Chest pain—Bupropion—obesity	0.000119	0.0012	CcSEcCtD
Terazosin—Arthralgia—Bupropion—obesity	0.000119	0.0012	CcSEcCtD
Terazosin—Anxiety—Bupropion—obesity	0.000119	0.0012	CcSEcCtD
Terazosin—Insomnia—Sibutramine—obesity	0.000118	0.00119	CcSEcCtD
Terazosin—Pollakiuria—Topiramate—obesity	0.000118	0.00119	CcSEcCtD
Terazosin—Erectile dysfunction—Topiramate—obesity	0.000118	0.00119	CcSEcCtD
Terazosin—Discomfort—Bupropion—obesity	0.000118	0.00119	CcSEcCtD
Terazosin—Decreased appetite—Orlistat—obesity	0.000117	0.00119	CcSEcCtD
Terazosin—Paraesthesia—Sibutramine—obesity	0.000117	0.00119	CcSEcCtD
Terazosin—Dyspnoea—Sibutramine—obesity	0.000117	0.00118	CcSEcCtD
Terazosin—Photosensitivity reaction—Topiramate—obesity	0.000117	0.00118	CcSEcCtD
Terazosin—Fatigue—Orlistat—obesity	0.000117	0.00118	CcSEcCtD
Terazosin—Dry mouth—Bupropion—obesity	0.000116	0.00117	CcSEcCtD
Terazosin—Somnolence—Sibutramine—obesity	0.000116	0.00117	CcSEcCtD
Terazosin—Weight increased—Topiramate—obesity	0.000116	0.00117	CcSEcCtD
Terazosin—Pain—Orlistat—obesity	0.000116	0.00117	CcSEcCtD
Terazosin—Dyspepsia—Sibutramine—obesity	0.000115	0.00116	CcSEcCtD
Terazosin—Confusional state—Bupropion—obesity	0.000115	0.00116	CcSEcCtD
Terazosin—Anaphylactic shock—Bupropion—obesity	0.000114	0.00115	CcSEcCtD
Terazosin—Oedema—Bupropion—obesity	0.000114	0.00115	CcSEcCtD
Terazosin—Decreased appetite—Sibutramine—obesity	0.000114	0.00115	CcSEcCtD
Terazosin—Depression—Topiramate—obesity	0.000114	0.00115	CcSEcCtD
Terazosin—Shock—Bupropion—obesity	0.000112	0.00113	CcSEcCtD
Terazosin—Pain—Sibutramine—obesity	0.000112	0.00113	CcSEcCtD
Terazosin—Constipation—Sibutramine—obesity	0.000112	0.00113	CcSEcCtD
Terazosin—Thrombocytopenia—Bupropion—obesity	0.000112	0.00113	CcSEcCtD
Terazosin—Feeling abnormal—Orlistat—obesity	0.000111	0.00112	CcSEcCtD
Terazosin—Tachycardia—Bupropion—obesity	0.000111	0.00112	CcSEcCtD
Terazosin—Urinary tract infection—Topiramate—obesity	0.000111	0.00112	CcSEcCtD
Terazosin—Conjunctivitis—Topiramate—obesity	0.000111	0.00112	CcSEcCtD
Terazosin—Gastrointestinal pain—Orlistat—obesity	0.000111	0.00112	CcSEcCtD
Terazosin—Hyperhidrosis—Bupropion—obesity	0.00011	0.00111	CcSEcCtD
Terazosin—Anorexia—Bupropion—obesity	0.000109	0.0011	CcSEcCtD
Terazosin—Feeling abnormal—Sibutramine—obesity	0.000108	0.00109	CcSEcCtD
Terazosin—Epistaxis—Topiramate—obesity	0.000107	0.00108	CcSEcCtD
Terazosin—Gastrointestinal pain—Sibutramine—obesity	0.000107	0.00108	CcSEcCtD
Terazosin—Sinusitis—Topiramate—obesity	0.000107	0.00108	CcSEcCtD
Terazosin—Abdominal pain—Orlistat—obesity	0.000107	0.00108	CcSEcCtD
Terazosin—Body temperature increased—Orlistat—obesity	0.000107	0.00108	CcSEcCtD
Terazosin—Hypotension—Bupropion—obesity	0.000107	0.00108	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Bupropion—obesity	0.000104	0.00105	CcSEcCtD
Terazosin—Abdominal pain—Sibutramine—obesity	0.000103	0.00104	CcSEcCtD
Terazosin—Body temperature increased—Sibutramine—obesity	0.000103	0.00104	CcSEcCtD
Terazosin—Insomnia—Bupropion—obesity	0.000103	0.00104	CcSEcCtD
Terazosin—Rhinitis—Topiramate—obesity	0.000103	0.00103	CcSEcCtD
Terazosin—Paraesthesia—Bupropion—obesity	0.000102	0.00103	CcSEcCtD
Terazosin—Dyspnoea—Bupropion—obesity	0.000102	0.00103	CcSEcCtD
Terazosin—Pharyngitis—Topiramate—obesity	0.000101	0.00102	CcSEcCtD
Terazosin—Somnolence—Bupropion—obesity	0.000101	0.00102	CcSEcCtD
Terazosin—Oedema peripheral—Topiramate—obesity	0.000101	0.00102	CcSEcCtD
Terazosin—Dyspepsia—Bupropion—obesity	0.0001	0.00101	CcSEcCtD
Terazosin—Hypersensitivity—Orlistat—obesity	9.96e-05	0.00101	CcSEcCtD
Terazosin—Decreased appetite—Bupropion—obesity	9.91e-05	0.001	CcSEcCtD
Terazosin—Visual impairment—Topiramate—obesity	9.85e-05	0.000995	CcSEcCtD
Terazosin—Fatigue—Bupropion—obesity	9.83e-05	0.000992	CcSEcCtD
Terazosin—Constipation—Bupropion—obesity	9.75e-05	0.000984	CcSEcCtD
Terazosin—Pain—Bupropion—obesity	9.75e-05	0.000984	CcSEcCtD
Terazosin—Asthenia—Orlistat—obesity	9.7e-05	0.000979	CcSEcCtD
Terazosin—Hypersensitivity—Sibutramine—obesity	9.64e-05	0.000973	CcSEcCtD
Terazosin—Pruritus—Orlistat—obesity	9.56e-05	0.000965	CcSEcCtD
Terazosin—Eye disorder—Topiramate—obesity	9.55e-05	0.000965	CcSEcCtD
Terazosin—Tinnitus—Topiramate—obesity	9.53e-05	0.000962	CcSEcCtD
Terazosin—Feeling abnormal—Bupropion—obesity	9.4e-05	0.000949	CcSEcCtD
Terazosin—Asthenia—Sibutramine—obesity	9.38e-05	0.000947	CcSEcCtD
Terazosin—Gastrointestinal pain—Bupropion—obesity	9.32e-05	0.000941	CcSEcCtD
Terazosin—Pruritus—Sibutramine—obesity	9.25e-05	0.000934	CcSEcCtD
Terazosin—Diarrhoea—Orlistat—obesity	9.25e-05	0.000933	CcSEcCtD
Terazosin—Body temperature increased—Bupropion—obesity	9.01e-05	0.00091	CcSEcCtD
Terazosin—Abdominal pain—Bupropion—obesity	9.01e-05	0.00091	CcSEcCtD
Terazosin—Diarrhoea—Sibutramine—obesity	8.95e-05	0.000903	CcSEcCtD
Terazosin—Dizziness—Orlistat—obesity	8.94e-05	0.000902	CcSEcCtD
Terazosin—Malnutrition—Topiramate—obesity	8.9e-05	0.000899	CcSEcCtD
Terazosin—Flatulence—Topiramate—obesity	8.77e-05	0.000885	CcSEcCtD
Terazosin—Tension—Topiramate—obesity	8.73e-05	0.000882	CcSEcCtD
Terazosin—Dysgeusia—Topiramate—obesity	8.72e-05	0.00088	CcSEcCtD
Terazosin—Dizziness—Sibutramine—obesity	8.65e-05	0.000873	CcSEcCtD
Terazosin—Nervousness—Topiramate—obesity	8.64e-05	0.000873	CcSEcCtD
Terazosin—Back pain—Topiramate—obesity	8.61e-05	0.000869	CcSEcCtD
Terazosin—Vomiting—Orlistat—obesity	8.59e-05	0.000867	CcSEcCtD
Terazosin—Rash—Orlistat—obesity	8.52e-05	0.00086	CcSEcCtD
Terazosin—Dermatitis—Orlistat—obesity	8.51e-05	0.000859	CcSEcCtD
Terazosin—Headache—Orlistat—obesity	8.47e-05	0.000855	CcSEcCtD
Terazosin—Hypersensitivity—Bupropion—obesity	8.4e-05	0.000848	CcSEcCtD
Terazosin—Vision blurred—Topiramate—obesity	8.39e-05	0.000847	CcSEcCtD
Terazosin—Tremor—Topiramate—obesity	8.34e-05	0.000842	CcSEcCtD
Terazosin—Vomiting—Sibutramine—obesity	8.32e-05	0.000839	CcSEcCtD
Terazosin—Ill-defined disorder—Topiramate—obesity	8.26e-05	0.000834	CcSEcCtD
Terazosin—Rash—Sibutramine—obesity	8.25e-05	0.000832	CcSEcCtD
Terazosin—Dermatitis—Sibutramine—obesity	8.24e-05	0.000832	CcSEcCtD
Terazosin—Headache—Sibutramine—obesity	8.19e-05	0.000827	CcSEcCtD
Terazosin—Asthenia—Bupropion—obesity	8.18e-05	0.000826	CcSEcCtD
Terazosin—Pruritus—Bupropion—obesity	8.07e-05	0.000814	CcSEcCtD
Terazosin—Nausea—Orlistat—obesity	8.03e-05	0.00081	CcSEcCtD
Terazosin—Malaise—Topiramate—obesity	8.03e-05	0.00081	CcSEcCtD
Terazosin—Vertigo—Topiramate—obesity	8e-05	0.000807	CcSEcCtD
Terazosin—Syncope—Topiramate—obesity	7.98e-05	0.000806	CcSEcCtD
Terazosin—Palpitations—Topiramate—obesity	7.87e-05	0.000794	CcSEcCtD
Terazosin—Loss of consciousness—Topiramate—obesity	7.82e-05	0.00079	CcSEcCtD
Terazosin—Diarrhoea—Bupropion—obesity	7.8e-05	0.000788	CcSEcCtD
Terazosin—Nausea—Sibutramine—obesity	7.77e-05	0.000784	CcSEcCtD
Terazosin—Cough—Topiramate—obesity	7.77e-05	0.000784	CcSEcCtD
Terazosin—Convulsion—Topiramate—obesity	7.71e-05	0.000779	CcSEcCtD
Terazosin—Chest pain—Topiramate—obesity	7.58e-05	0.000765	CcSEcCtD
Terazosin—Myalgia—Topiramate—obesity	7.58e-05	0.000765	CcSEcCtD
Terazosin—Arthralgia—Topiramate—obesity	7.58e-05	0.000765	CcSEcCtD
Terazosin—Anxiety—Topiramate—obesity	7.55e-05	0.000762	CcSEcCtD
Terazosin—Dizziness—Bupropion—obesity	7.54e-05	0.000761	CcSEcCtD
Terazosin—Discomfort—Topiramate—obesity	7.49e-05	0.000756	CcSEcCtD
Terazosin—Dry mouth—Topiramate—obesity	7.41e-05	0.000748	CcSEcCtD
Terazosin—Confusional state—Topiramate—obesity	7.32e-05	0.000739	CcSEcCtD
Terazosin—Oedema—Topiramate—obesity	7.26e-05	0.000733	CcSEcCtD
Terazosin—Vomiting—Bupropion—obesity	7.25e-05	0.000732	CcSEcCtD
Terazosin—Rash—Bupropion—obesity	7.19e-05	0.000726	CcSEcCtD
Terazosin—Dermatitis—Bupropion—obesity	7.18e-05	0.000725	CcSEcCtD
Terazosin—Shock—Topiramate—obesity	7.15e-05	0.000721	CcSEcCtD
Terazosin—Headache—Bupropion—obesity	7.14e-05	0.000721	CcSEcCtD
Terazosin—Thrombocytopenia—Topiramate—obesity	7.11e-05	0.000718	CcSEcCtD
Terazosin—Tachycardia—Topiramate—obesity	7.09e-05	0.000716	CcSEcCtD
Terazosin—Hyperhidrosis—Topiramate—obesity	7.02e-05	0.000709	CcSEcCtD
Terazosin—Anorexia—Topiramate—obesity	6.92e-05	0.000699	CcSEcCtD
Terazosin—Hypotension—Topiramate—obesity	6.79e-05	0.000685	CcSEcCtD
Terazosin—Nausea—Bupropion—obesity	6.77e-05	0.000684	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Topiramate—obesity	6.62e-05	0.000668	CcSEcCtD
Terazosin—Insomnia—Topiramate—obesity	6.57e-05	0.000663	CcSEcCtD
Terazosin—Paraesthesia—Topiramate—obesity	6.52e-05	0.000659	CcSEcCtD
Terazosin—Dyspnoea—Topiramate—obesity	6.48e-05	0.000654	CcSEcCtD
Terazosin—Somnolence—Topiramate—obesity	6.46e-05	0.000652	CcSEcCtD
Terazosin—Dyspepsia—Topiramate—obesity	6.39e-05	0.000646	CcSEcCtD
Terazosin—Decreased appetite—Topiramate—obesity	6.31e-05	0.000637	CcSEcCtD
Terazosin—Fatigue—Topiramate—obesity	6.26e-05	0.000632	CcSEcCtD
Terazosin—Constipation—Topiramate—obesity	6.21e-05	0.000627	CcSEcCtD
Terazosin—Pain—Topiramate—obesity	6.21e-05	0.000627	CcSEcCtD
Terazosin—Feeling abnormal—Topiramate—obesity	5.99e-05	0.000604	CcSEcCtD
Terazosin—Gastrointestinal pain—Topiramate—obesity	5.94e-05	0.0006	CcSEcCtD
Terazosin—Body temperature increased—Topiramate—obesity	5.74e-05	0.00058	CcSEcCtD
Terazosin—Abdominal pain—Topiramate—obesity	5.74e-05	0.00058	CcSEcCtD
Terazosin—Hypersensitivity—Topiramate—obesity	5.35e-05	0.00054	CcSEcCtD
Terazosin—Asthenia—Topiramate—obesity	5.21e-05	0.000526	CcSEcCtD
Terazosin—Pruritus—Topiramate—obesity	5.14e-05	0.000519	CcSEcCtD
Terazosin—Diarrhoea—Topiramate—obesity	4.97e-05	0.000502	CcSEcCtD
Terazosin—Dizziness—Topiramate—obesity	4.8e-05	0.000485	CcSEcCtD
Terazosin—Vomiting—Topiramate—obesity	4.62e-05	0.000466	CcSEcCtD
Terazosin—Rash—Topiramate—obesity	4.58e-05	0.000462	CcSEcCtD
Terazosin—Dermatitis—Topiramate—obesity	4.58e-05	0.000462	CcSEcCtD
Terazosin—Headache—Topiramate—obesity	4.55e-05	0.000459	CcSEcCtD
Terazosin—Nausea—Topiramate—obesity	4.31e-05	0.000436	CcSEcCtD
Terazosin—ADRA1A—Signaling Pathways—PARP1—obesity	4.73e-06	7.74e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—GHRL—obesity	4.73e-06	7.74e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—DPYD—obesity	4.72e-06	7.72e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CCL5—obesity	4.71e-06	7.7e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—DRD4—obesity	4.69e-06	7.68e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—POMC—obesity	4.66e-06	7.62e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PRL—obesity	4.65e-06	7.6e-05	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—APOA1—obesity	4.62e-06	7.55e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—LPL—obesity	4.61e-06	7.53e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—STK11—obesity	4.58e-06	7.49e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—FOXO1—obesity	4.57e-06	7.48e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—RPS6KB1—obesity	4.57e-06	7.47e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—CCL2—obesity	4.56e-06	7.46e-05	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—POMC—obesity	4.56e-06	7.46e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—F2—obesity	4.54e-06	7.43e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—PRKCB—obesity	4.54e-06	7.43e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PRKAR2B—obesity	4.54e-06	7.43e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PLG—obesity	4.53e-06	7.41e-05	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—RHOA—obesity	4.52e-06	7.4e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—PIK3CB—obesity	4.52e-06	7.39e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—DCN—obesity	4.51e-06	7.38e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CNR1—obesity	4.48e-06	7.33e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—AKT2—obesity	4.48e-06	7.33e-05	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—PIK3R1—obesity	4.48e-06	7.32e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—FOXO3—obesity	4.42e-06	7.23e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—ADRB2—obesity	4.41e-06	7.21e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—TCF7L2—obesity	4.4e-06	7.2e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CPT1A—obesity	4.39e-06	7.18e-05	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—AKT2—obesity	4.38e-06	7.17e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—DRD2—obesity	4.37e-06	7.15e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—PIK3CG—obesity	4.35e-06	7.11e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—SOCS1—obesity	4.34e-06	7.1e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—GCG—obesity	4.33e-06	7.08e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PTPN1—obesity	4.33e-06	7.08e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—PIK3CD—obesity	4.3e-06	7.04e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—NAMPT—obesity	4.3e-06	7.04e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—SOCS3—obesity	4.29e-06	7.02e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—LIPC—obesity	4.28e-06	6.99e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—GCK—obesity	4.28e-06	6.99e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—APOC3—obesity	4.25e-06	6.95e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PRKCD—obesity	4.24e-06	6.94e-05	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—PIK3CD—obesity	4.21e-06	6.89e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—GNB3—obesity	4.2e-06	6.87e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—HTR2A—obesity	4.15e-06	6.79e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—C3—obesity	4.15e-06	6.78e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—TYK2—obesity	4.14e-06	6.77e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—POMC—obesity	4.14e-06	6.77e-05	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—PIK3CB—obesity	4.13e-06	6.76e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PRL—obesity	4.13e-06	6.75e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CETP—obesity	4.13e-06	6.75e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IGF2—obesity	4.12e-06	6.75e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—RHOA—obesity	4.11e-06	6.72e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—GNAS—obesity	4.09e-06	6.69e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—SDC1—obesity	4.08e-06	6.67e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—STK11—obesity	4.07e-06	6.65e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—PIK3R1—obesity	4.06e-06	6.65e-05	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—obesity	4.05e-06	6.62e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—CCL2—obesity	4.05e-06	6.62e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PLG—obesity	4.02e-06	6.58e-05	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—RHOA—obesity	4.02e-06	6.57e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—AKR1C3—obesity	4.01e-06	6.56e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—APOB—obesity	4e-06	6.55e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—AKT2—obesity	3.98e-06	6.51e-05	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—PIK3R1—obesity	3.98e-06	6.5e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—SCARB1—obesity	3.95e-06	6.46e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IRS2—obesity	3.95e-06	6.45e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—AGT—obesity	3.94e-06	6.45e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—FOXO3—obesity	3.93e-06	6.42e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—ADRB2—obesity	3.92e-06	6.41e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CCL5—obesity	3.91e-06	6.39e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—APOE—obesity	3.86e-06	6.32e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—LEP—obesity	3.86e-06	6.32e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—SOCS1—obesity	3.86e-06	6.31e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—SREBF1—obesity	3.84e-06	6.27e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CAV1—obesity	3.83e-06	6.26e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—LPL—obesity	3.82e-06	6.25e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—PIK3CD—obesity	3.82e-06	6.25e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—APOA1—obesity	3.82e-06	6.24e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—SOCS3—obesity	3.81e-06	6.23e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—FOXO1—obesity	3.8e-06	6.21e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—RPS6KB1—obesity	3.79e-06	6.2e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—PIK3CB—obesity	3.75e-06	6.14e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—GOT2—obesity	3.73e-06	6.1e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—GNB3—obesity	3.73e-06	6.1e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—ESR1—obesity	3.69e-06	6.03e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—TYK2—obesity	3.68e-06	6.02e-05	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—PIK3CB—obesity	3.67e-06	6e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IGF2—obesity	3.66e-06	5.99e-05	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—ALB—obesity	3.66e-06	5.98e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—FASN—obesity	3.65e-06	5.97e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—RHOA—obesity	3.65e-06	5.97e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—F2—obesity	3.64e-06	5.96e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PRKCB—obesity	3.64e-06	5.96e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—BCHE—obesity	3.64e-06	5.95e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—GNAS—obesity	3.63e-06	5.94e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—PIK3R1—obesity	3.61e-06	5.9e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—BAD—obesity	3.6e-06	5.88e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—APOB—obesity	3.56e-06	5.82e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PRKCD—obesity	3.52e-06	5.76e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CYP2E1—obesity	3.51e-06	5.74e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PIK3CG—obesity	3.49e-06	5.7e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CCL5—obesity	3.47e-06	5.68e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—NQO1—obesity	3.47e-06	5.67e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—HTR2A—obesity	3.45e-06	5.64e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IRS1—obesity	3.44e-06	5.63e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—C3—obesity	3.44e-06	5.63e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—LPL—obesity	3.4e-06	5.55e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—FOXO1—obesity	3.37e-06	5.51e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—RPS6KB1—obesity	3.37e-06	5.5e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—PIK3CB—obesity	3.33e-06	5.45e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—GCG—obesity	3.33e-06	5.44e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—SLC2A4—obesity	3.33e-06	5.44e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—POMC—obesity	3.32e-06	5.43e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—INS—obesity	3.3e-06	5.39e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CYCS—obesity	3.28e-06	5.37e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IRS2—obesity	3.28e-06	5.36e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—AGT—obesity	3.27e-06	5.35e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CCL2—obesity	3.25e-06	5.31e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—GOT1—obesity	3.22e-06	5.27e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—GGT1—obesity	3.22e-06	5.27e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—LEP—obesity	3.21e-06	5.24e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—APOE—obesity	3.21e-06	5.24e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IGF1—obesity	3.19e-06	5.22e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—AKT2—obesity	3.19e-06	5.21e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CAV1—obesity	3.18e-06	5.19e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—NCOA1—obesity	3.17e-06	5.19e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—APOA1—obesity	3.17e-06	5.18e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PRKCD—obesity	3.13e-06	5.12e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CYP19A1—obesity	3.13e-06	5.11e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—STK11—obesity	3.13e-06	5.11e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PIK3CD—obesity	3.06e-06	5.01e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—HTR2A—obesity	3.06e-06	5.01e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—ESR1—obesity	3.06e-06	5e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—C3—obesity	3.06e-06	5e-05	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—PIK3CA—obesity	3.03e-06	4.96e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—SERPINE1—obesity	3.03e-06	4.96e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—F2—obesity	3.02e-06	4.94e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PRKCB—obesity	3.02e-06	4.94e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—BAD—obesity	2.99e-06	4.88e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—TYK2—obesity	2.95e-06	4.82e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—RHOA—obesity	2.92e-06	4.78e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IRS2—obesity	2.91e-06	4.76e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—COMT—obesity	2.91e-06	4.75e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—AGT—obesity	2.91e-06	4.75e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—NOS3—obesity	2.89e-06	4.73e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PIK3R1—obesity	2.89e-06	4.73e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PIK3CG—obesity	2.89e-06	4.73e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PPARGC1A—obesity	2.87e-06	4.69e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—GNB3—obesity	2.87e-06	4.69e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IRS1—obesity	2.86e-06	4.68e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—HMOX1—obesity	2.85e-06	4.67e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—APOE—obesity	2.85e-06	4.66e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—LEP—obesity	2.85e-06	4.66e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CAV1—obesity	2.82e-06	4.61e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—APOA1—obesity	2.81e-06	4.6e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—GNAS—obesity	2.79e-06	4.56e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—PIK3CA—obesity	2.76e-06	4.51e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—POMC—obesity	2.75e-06	4.5e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—INS—obesity	2.74e-06	4.48e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—APOB—obesity	2.73e-06	4.47e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—ESR1—obesity	2.72e-06	4.44e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CCL2—obesity	2.69e-06	4.41e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PRKCB—obesity	2.68e-06	4.39e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—F2—obesity	2.68e-06	4.39e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PIK3CB—obesity	2.67e-06	4.37e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—MTOR—obesity	2.67e-06	4.37e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—BAD—obesity	2.65e-06	4.34e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IGF1—obesity	2.65e-06	4.33e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—AKT2—obesity	2.65e-06	4.33e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—LPL—obesity	2.61e-06	4.27e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PIK3CG—obesity	2.57e-06	4.2e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—GPX1—obesity	2.55e-06	4.16e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PIK3CD—obesity	2.54e-06	4.16e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IRS1—obesity	2.54e-06	4.15e-05	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—PIK3CA—obesity	2.52e-06	4.12e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—SERPINE1—obesity	2.52e-06	4.11e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CD36—obesity	2.48e-06	4.06e-05	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—AKT1—obesity	2.48e-06	4.05e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—TYK2—obesity	2.45e-06	4e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—POMC—obesity	2.45e-06	4e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—IL6—obesity	2.44e-06	3.99e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—INS—obesity	2.43e-06	3.98e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—RHOA—obesity	2.43e-06	3.97e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PIK3R1—obesity	2.4e-06	3.93e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—NOS3—obesity	2.4e-06	3.93e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CCL2—obesity	2.39e-06	3.91e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IGF1—obesity	2.35e-06	3.85e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—AKT2—obesity	2.35e-06	3.84e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—MTHFR—obesity	2.35e-06	3.84e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—MMP9—obesity	2.32e-06	3.8e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PPARA—obesity	2.31e-06	3.77e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—PIK3CA—obesity	2.29e-06	3.74e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PIK3CD—obesity	2.26e-06	3.69e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—MAPK8—obesity	2.26e-06	3.69e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—AKT1—obesity	2.25e-06	3.68e-05	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—PIK3CA—obesity	2.24e-06	3.66e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—SERPINE1—obesity	2.23e-06	3.65e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—AGT—obesity	2.23e-06	3.65e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—MTOR—obesity	2.22e-06	3.62e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PIK3CB—obesity	2.22e-06	3.62e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—APOE—obesity	2.19e-06	3.58e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—TYK2—obesity	2.17e-06	3.55e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CAV1—obesity	2.17e-06	3.54e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—APOA1—obesity	2.16e-06	3.54e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—RHOA—obesity	2.16e-06	3.52e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PIK3R1—obesity	2.13e-06	3.49e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—NOS3—obesity	2.13e-06	3.49e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—STAT3—obesity	2.06e-06	3.37e-05	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—AKT1—obesity	2.06e-06	3.36e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—PIK3CA—obesity	2.03e-06	3.32e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—IL6—obesity	2.03e-06	3.31e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PIK3CG—obesity	1.97e-06	3.23e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—MTOR—obesity	1.97e-06	3.22e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PIK3CB—obesity	1.97e-06	3.22e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—MMP9—obesity	1.93e-06	3.15e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—MYC—obesity	1.92e-06	3.14e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—TGFB1—obesity	1.91e-06	3.13e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PPARG—obesity	1.91e-06	3.12e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—POMC—obesity	1.88e-06	3.07e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—MAPK8—obesity	1.87e-06	3.06e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—INS—obesity	1.87e-06	3.06e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—AKT1—obesity	1.87e-06	3.06e-05	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—AKT1—obesity	1.83e-06	2.99e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—IL6—obesity	1.8e-06	2.94e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PIK3CD—obesity	1.74e-06	2.84e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—ALB—obesity	1.71e-06	2.8e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—STAT3—obesity	1.71e-06	2.8e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—MMP9—obesity	1.71e-06	2.8e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—MAPK8—obesity	1.66e-06	2.72e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—AKT1—obesity	1.66e-06	2.71e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PIK3R1—obesity	1.64e-06	2.68e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—NOS3—obesity	1.64e-06	2.68e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PIK3CA—obesity	1.63e-06	2.66e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—MYC—obesity	1.59e-06	2.6e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—TGFB1—obesity	1.59e-06	2.6e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—STAT3—obesity	1.52e-06	2.49e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PIK3CB—obesity	1.51e-06	2.47e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PTGS2—obesity	1.5e-06	2.45e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IL6—obesity	1.44e-06	2.36e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—MYC—obesity	1.41e-06	2.31e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—TGFB1—obesity	1.41e-06	2.31e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PIK3CA—obesity	1.35e-06	2.21e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—AKT1—obesity	1.33e-06	2.17e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PIK3CA—obesity	1.2e-06	1.96e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IL6—obesity	1.2e-06	1.96e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—AKT1—obesity	1.1e-06	1.81e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IL6—obesity	1.06e-06	1.74e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—AKT1—obesity	9.8e-07	1.6e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PIK3CA—obesity	9.22e-07	1.51e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—AKT1—obesity	7.53e-07	1.23e-05	CbGpPWpGaD
